Antheia, Inc. on LinkedIn: #antheia #biomanufacturing #pharma #supplychains (2024)

One last chance to hear from Antheia’s CEO and co-founder, Dr. Christina Smolke at CPHI Milan this week. Join the upcoming panel to hear from thought leaders on how we can build a more diverse and inclusive pharma industry. See you soon!

7

This morning, CEO and co-founder, Dr. Christina Smolke joins the CPHI Milan roundtable to share her perspective on the key trends shaping the industry in 2025. Looking forward to an insightful discussion among industry leaders.

13

Happening soon at the Next-Gen Bio Theatre at CPHI Milan: CEO and co-founder, Dr. Christina Smolke is speaking on a panel of leading experts on the latest trends in #biomanufacturing. See you there!

12

We’re gearing up for an exciting week at CPHI Global in Milan. If you’re attending, be sure to join CEO and co-founder, Dr. Christina Smolke as she presents this week on everything from global trends in biomanufacturing to 2025 outlooks for pharma to the importance of diversity and inclusion in the industry. Add these sessions to your calendar!

19

As we scale our global commercialization strategy, our network of trusted partners also continues to steadily grow. We’re proud to share that we are working with PS Pharma Service GmbH, a leading provider in Europe for pharmaceutical warehousing, logistics, manufacturing, and transportation. With more than 30 years of experience in the pharmaceutical ingredients market, PS Pharma will play a critical role in supporting our third-party logistics for our first products in Europe. We look forward to deepening this partnership as we continue our efforts to transform pharma supply chains with the power of biomanufacturing. #Antheia #Biomanufacturing #PharmaSupplyChains

49

2 Comments

Attending CPHI Global in Milan next week? Be sure to get in touch with our team via the CPHI app: Christina Smolke, Richard Sherwin, Guerin Kob, Yen-Hsiang W..We’re looking forward to seeing you there and discussing all things #pharma #supplychains.

12

Ahead of CPHI Milan next month, CEO and Co-Founder Dr. Christina Smolke joined other dynamic industry leaders to discuss the critical role of diverse and inclusive leadership in pharma. She emphasized the importance of embracing diversity to deliver effective solutions: “No one group has a monopoly on good ideas, so we need to create more opportunities for problem-solvers of all backgrounds to lead the constant evolution and innovation this industry requires. With a more nuanced sense of healthcare challenges across demographics, we can improve health outcomes for more people.”Read her full thoughts here: https://bit.ly/3ZDPx2CIf you’re attending CPHI Milan, be sure to add the panel “Leading with Diversity: The CEO Journey” on October 10 to your agenda to hear more from Christina and these leaders on advancing DEI in the pharma industry.

17

Today, we’re highlighting the public health impact of Narcan, a vital opioid overdose rescue drug that is now available over the counter. The FDA’s approval of OTC Narcan in 2023 was a major step forward in the fight to save lives, but scaling up production to meet increased demand is much easier said than done for the pharma industry. Read our latest blog post to learn more about the supply chain challenges impacting Narcan availability, and how biomanufacturing can help the industry respond more quickly to spikes in demand for essential medicines. https://bit.ly/3XTM7aK #Antheia #biomanufacturing #pharma #Narcan

32

1 Comment

CEO and co-founder, Dr. Christina Smolke will be taking the stage at CPHI Milan next month, discussing everything from global trends in biomanufacturing to 2025 outlooks for pharma to the importance of diversity and inclusion in the industry. Mark your calendars and we look forward to seeing you there! #Antheia #CPHIGlobal #CPHIMilan #biomanufacturing #pharmasupplychains

42